학술논문

Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center.
Document Type
Article
Source
JCO Oncology Practice; May2022, Vol. 18 Issue 5, pe642-e647, 6p
Subject
MEDICAL quality control
PROTEINS
GENETIC mutation
SPECIALTY hospitals
CONFIDENCE intervals
MOLECULAR diagnosis
MELANOMA
ONCOGENES
LOG-rank test
MOLECULAR pathology
TERTIARY care
RETROSPECTIVE studies
ACQUISITION of data
CANCER treatment
TREATMENT delay (Medicine)
TURNAROUND time
TRANSFERASES
MEDICAL records
DESCRIPTIVE statistics
MEDICAL appointments
EARLY medical intervention
CANCER patient medical care
LONGITUDINAL method
Language
ISSN
26881527
Abstract
Copyright of JCO Oncology Practice is the property of American Society of Clinical Oncology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)